Your browser doesn't support javascript.
loading
Additive effects of a family history of schizophrenia spectrum disorders and an environmental risk score for the outcome of patients with non-affective first-episode psychosis.
Cuesta, Manuel J; García de Jalón, Elena; Sánchez-Torres, Ana M; Gil-Berrozpe, Gustavo J; Aranguren, Lidia; Gutierrez, Gerardo; Corrales, Asier; Zarzuela, Amalia; Ibañez, Berta; Peralta, Víctor.
Afiliação
  • Cuesta MJ; Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain.
  • García de Jalón E; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Sánchez-Torres AM; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Gil-Berrozpe GJ; Mental Health Department, Servicio Navarro de Salud - Osasunbidea, Pamplona, Spain.
  • Aranguren L; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Gutierrez G; Departament of Health Sciences, Universidad Pública de Navarra (UPNA), Pamplona, Spain.
  • Corrales A; Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain.
  • Zarzuela A; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Ibañez B; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Peralta V; Mental Health Department, Servicio Navarro de Salud - Osasunbidea, Pamplona, Spain.
Psychol Med ; 54(10): 2435-2443, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38505954
ABSTRACT

BACKGROUND:

First-episode psychotic disorders comprise a heterogeneous phenotype with a complex etiology involving numerous common small-effect genetic variations and a wide range of environmental exposures. We examined whether a family of schizophrenia spectrum disorder (FH-Sz) interacts with an environmental risk score (ERS-Sz) regarding the outcome of patients with non-affective first episode psychosis (NAFEP).

METHODS:

We included 288 patients with NAFEP who were evaluated after discharge from an intensive 2-year program. We evaluated three outcome

measures:

symptomatic remission, psychosocial functioning, and personal recovery. We analyzed the main and joint associations of a FH-Sz and the ERS-Sz on the outcomes by using the relative excess risk due to interaction (RERI) approach.

RESULTS:

A FH-Sz showed a significant association with poor symptomatic remission and psychosocial functioning outcomes, although there was no significant interaction between a FH-Sz and the ERS-Sz on these outcomes. The ERS-Sz did not show a significant association with poor symptomatic remission and psychosocial functioning outcomes, even though the magnitude of the interaction between ERS-Sz and FH-Sz with the later outcome was moderate (RERI = 6.89, 95% confidence interval -16.03 to 29.81). There was no association between a FH-Sz and the ERS-Sz and personal recovery.

CONCLUSIONS:

Our results provide further empirical support regarding the contribution of FH-Sz to poor symptomatic remission and poor psychosocial functioning outcomes in patients with NAFEP.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article